Bonesupport Holding AB (publ) (FRA:2B4)

Market Cap	1.36B -19.5%
Revenue (ttm)	110.74M +21.8%
Net Income	16.87M +51.3%
EPS	0.25 +50.7%
Shares Out	n/a
PE Ratio	80.76
Forward PE	41.70
Dividend	n/a
Ex-Dividend Date	n/a

Volume	150
Open	20.30
Previous Close	20.52
Day's Range	20.26 - 20.30
52-Week Range	15.50 - 30.66
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 16, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone gra...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 160
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2B4

Financial Performance

In 2025, Bonesupport Holding AB's revenue was 1.17 billion, an increase of 30.70% compared to the previous year's 898.73 million. Earnings were 142.15 million, an increase of 6.28%.

Financial numbers in SEK